🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05475015
Recruiting Observational

3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension

NCT05475015 · tracked via the Priya Life Science China tracker
Sponsor
Shengjing Hospital
Phase
Observational
Started
2022-08-16
Last updated
2026-02-09

Condition(s) studied

Cirrhosis, LiverPortal HypertensionAdvanced Chronic Liver Disease

Investigational drug(s) / intervention(s)

3D-MREHVPG

3D-MRE: All imaging studies were performed by using a 3.0-T MRI system ( GE Healthcare) with a phasedarray body coil.

HVPG: HVPG measurements are performed by well-trained interventional radiologists in accordance with standard operating procedures.

Study summary

How to construct a novel, non-invasive, accurate, and convenient method to achieve prediction of hepatic venous pressure gradient (HVPG) is an important general problem in the management of portal hypertension in cirrhosis or advanced chronic liver disease. We plan to investigate the ability of three demensional-magnetic resonance elastography (3D-MRE) to establish a risk stratification system and perform tailored management for portal hypertension in cirrhosis or advanced chronic liver disease.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion criteria were: (1) ≥18 years; (2) written informed consent; (3) confirmed ACLD of any liver disease etiology; (4) clinically indicated for HVPG measurement, with 3D-MRE performed within one month prior. Exclusion criteria were: (1) hepatic or extrahepatic malignancies, or large hepatic or splenic focal diseases affecting MRE measurement; (2) MR or HVPG contraindications; (3) prior liver or splenic surgery affecting MRE measurement; (4) treatment with nonselective β-blockers (NSBB) between MRE and HVPG measurements; (5) invalid or unreliable HVPG or MRE results and (6) biliary obstruction or dilation on MR images.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shengjing Hospital Shenyang Liaoning Recruiting

More Shengjing Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05475015 on ClinicalTrials.gov ↗ ← All trials in China